Wenwen Gao
Research Subjects
Research Interests
Wenwen Gao has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Chaokun Li
Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Henan Medical University, Xinxiang, China
1 shared publication - Guomin Shen
Department of hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, People's Republic of China; Department of Cell Biology, School of Basic Medical Sciences, Harbin Medical University, Harbin, Heilongjiang, People's Republic of China
1 shared publication - Hai-Chuan Yu
School of Medical Technology, Henan Medical University, Xinxiang, China
1 shared publication Haiping Yang
Department of Medical Genetics, Institute of Hemostasis and Thrombosis, School of Basic Medical Sciences, and
1 shared publication- Hongli Liu
School of Interdisciplinary Medicine and Engineering, Harbin Medical University, Harbin, People's Republic of China
1 shared publication - Longteng Cui
Department of Medical Genetics, Institute of Hemostasis and Thrombosis, School of Basic Medical Sciences, and
1 shared publication
Latest Publications
- Open Access
- 7 August 2020
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (15) , 3659-3667
Characterization of missense mutations in the signal peptide and propeptide of FIX in hemophilia B by a cell-based assay
Many mutations in the signal peptide and propeptide of factor IX (FIX) cause hemophilia B. A FIX variants database reports 28 unique missense mutations in these regions that lead to FIX deficiency, but the underlying mechanism is known only for the mutations on R43 that interfere with propeptide cleavage. It remains unclear how other mutations result in FIX deficiency and why patients carrying the same mutation have different bleeding tendencies. Here, we modify a cell-based reporter assay to characterize the missense mutations in the signal peptide and propeptide of FIX. The results show that the level of secreted conformation-specific reporter (SCSR), which has a functional γ-carboxyglutamate (Gla) domain of FIX, decreases significantly in most mutations. The decreased SCSR level is consistent with FIX deficiency in hemophilia B patients. Moreover, we find that the decrease in the SCSR level is caused by several distinct mechanisms, including interfering with cotranslational translocation into the endoplasmic reticulum, protein secretion, γ-carboxylation of the Gla domain, and cleavage of the signal peptide or propeptide. Importantly, our results also show that the SCSR levels of most signal peptide and propeptide mutations increase with vitamin K concentration, suggesting that the heterogeneity of bleeding tendencies may be related to vitamin K levels in the body. Thus, oral administration of vitamin K may alleviate the severity of bleeding tendencies in patients with missense mutations in the FIX signal peptide and propeptide regions.
- 7 August 2020
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (15) , 3659-3667
Open AccessCharacterization of missense mutations in the signal peptide and propeptide of FIX in hemophilia B by a cell-based assay
Many mutations in the signal peptide and propeptide of factor IX (FIX) cause hemophilia B. A FIX variants database reports 28 unique missense mutations in these regions that lead to FIX deficiency, but the underlying mechanism is known only for the mutations on R43 that interfere with propeptide cleavage. It remains unclear how other mutations result in FIX deficiency and why patients carrying the same mutation have different bleeding tendencies. Here, we modify a cell-based reporter assay to characterize the missense mutations in the signal peptide and propeptide of FIX. The results show that the level of secreted conformation-specific reporter (SCSR), which has a functional γ-carboxyglutamate (Gla) domain of FIX, decreases significantly in most mutations. The decreased SCSR level is consistent with FIX deficiency in hemophilia B patients. Moreover, we find that the decrease in the SCSR level is caused by several distinct mechanisms, including interfering with cotranslational translocation into the endoplasmic reticulum, protein secretion, γ-carboxylation of the Gla domain, and cleavage of the signal peptide or propeptide. Importantly, our results also show that the SCSR levels of most signal peptide and propeptide mutations increase with vitamin K concentration, suggesting that the heterogeneity of bleeding tendencies may be related to vitamin K levels in the body. Thus, oral administration of vitamin K may alleviate the severity of bleeding tendencies in patients with missense mutations in the FIX signal peptide and propeptide regions.